Internal Medicine

🩸 Anemias

Understanding the Blood Deficiency

Amos Asamoah
October 2025
7 min read
Hematology

Anemia represents one of the most prevalent hematological disorders worldwide, characterized by inadequate oxygen-carrying capacity due to reduced red blood cell mass or hemoglobin concentration. This comprehensive exploration covers the pathophysiological mechanisms, classification systems, diagnostic approaches, and clinical management strategies essential for understanding and treating these diverse conditions that affect nearly one-third of the global population.

🩸 Fundamentals of Anemia

Anemia is defined by quantitative reductions in key hematological parameters that impair oxygen delivery to tissues, triggering complex physiological adaptations and producing characteristic clinical manifestations:

Diagnostic Criteria

  • Hemoglobin: <13 g/dL (men), <12 g/dL (women), <11 g/dL (pregnancy)
  • Hematocrit: <39% (men), <36% (women)
  • RBC Count: <4.5 million/μL (men), <4.0 million/μL (women)
  • WHO Standards: Vary by age, sex, and physiological status
  • Clinical Context: Symptoms may precede laboratory abnormalities
  • Severity Grading: Mild (10-12 g/dL), Moderate (8-10 g/dL), Severe (<8 g/dL)

Pathophysiological Mechanisms

  • Blood Loss: Acute or chronic hemorrhage
  • Decreased Production: Nutritional deficiencies, bone marrow failure
  • Increased Destruction: Hemolysis, sequestration
  • Compensatory Responses: Increased cardiac output, oxygen extraction
  • Tissue Hypoxia: Cellular adaptation and damage
  • Clinical Manifestations: Fatigue, pallor, dyspnea, tachycardia
🎯 Clinical Memory Aid: Remember the three fundamental mechanisms of anemia: too much loss, too little production, or too much destruction. This framework provides the foundation for systematic diagnosis and classification.

🔬 Morphological Classification by MCV

Mean Corpuscular Volume (MCV) provides the primary morphological classification system, directing diagnostic evaluation toward specific etiological categories:

Category MCV Range Key Etiologies Diagnostic Approach Treatment Considerations
Microcytic <80 fL Iron deficiency, thalassemia, anemia of chronic disease, sideroblastic anemia Iron studies, hemoglobin electrophoresis, bone marrow examination Iron supplementation, underlying disease management
Normocytic 80-100 fL Early nutritional deficiencies, hemolytic anemias, bone marrow disorders, renal disease Reticulocyte count, Coombs test, renal function, bone marrow biopsy Treat underlying cause, erythropoietin for renal disease
Macrocytic >100 fL B12/folate deficiency, myelodysplasia, liver disease, hypothyroidism, medications B12/folate levels, thyroid function, LFTs, bone marrow examination B12/folate replacement, treat underlying disorders
🚨 Critical Diagnostic Step: Always assess reticulocyte count early in the evaluation. Increased reticulocytes indicate appropriate bone marrow response (hemolysis, blood loss), while decreased reticulocytes suggest production defects (nutritional deficiencies, bone marrow failure).

💊 Iron Deficiency Anemia

Iron deficiency represents the most common nutritional deficiency worldwide, progressing through distinct physiological stages from storage depletion to overt anemia:

Etiological Categories

  • Blood Loss: GI bleeding, menorrhagia, frequent phlebotomy
  • Increased Requirements: Pregnancy, lactation, growth periods
  • Decreased Absorption: Celiac disease, gastrectomy, H. pylori
  • Inadequate Intake: Nutritional deficiencies, restrictive diets
  • Clinical: Always investigate cause in adult men and postmenopausal women

Diagnostic Progression

  • Stage 1: Storage iron depletion (low ferritin)
  • Stage 2: Iron-deficient erythropoiesis (high TIBC, low transferrin saturation)
  • Stage 3: Frank anemia with microcytic, hypochromic cells
  • Laboratory: Progressive changes in iron studies and RBC indices
  • Clinical: Symptoms often appear in stage 3

Clinical Features

  • General: Fatigue, pallor, exertional dyspnea
  • Epithelial: Koilonychia, glossitis, angular cheilitis
  • Behavioral: Pica (especially pagophagia - ice craving)
  • Neurological: Restless legs syndrome (association)
  • Cardiac: Tachycardia, flow murmurs in severe cases
🔬 Clinical Insight: The RDW (Red Cell Distribution Width) is typically elevated early in iron deficiency, reflecting anisocytosis. This pattern helps distinguish iron deficiency from thalassemia trait, where RDW is usually normal despite microcytosis.

🧬 Megaloblastic Anemias

Megaloblastic anemias result from impaired DNA synthesis due to deficiencies in vitamin B12 or folate, characterized by distinctive morphological changes and clinical presentations:

Vitamin B12 Deficiency

  • Causes: Pernicious anemia, gastric surgery, Crohn's disease, vegan diet
  • Hematological: Macrocytic anemia, hypersegmented neutrophils, pancytopenia
  • Neurological: Symmetrical paresthesia, ataxia, cognitive changes
  • Diagnostic: Low B12, elevated methylmalonic acid and homocysteine
  • Treatment: Parenteral B12 initially, then maintenance therapy
  • Clinical: Neurological damage may be irreversible if treatment delayed

Folate Deficiency

  • Causes: Poor nutrition, alcoholism, pregnancy, methotrexate, malabsorption
  • Hematological: Identical to B12 deficiency morphologically
  • Neurological: No specific neurological manifestations (key distinction)
  • Diagnostic: Low folate, elevated homocysteine, normal methylmalonic acid
  • Treatment: Oral folate supplementation, dietary modification
  • Clinical: Rapid response to replacement therapy
⚠️ Critical Alert: Never administer folate without confirming B12 status. Folate can partially correct the hematological abnormalities of B12 deficiency while allowing progressive neurological deterioration—the "folate trap" phenomenon that can cause irreversible neurological damage.

⚡ Hemolytic Anemias

Hemolytic anemias encompass disorders characterized by premature red blood cell destruction, classified by defect location (intracorpuscular vs. extracorpuscular) and inheritance pattern:

Disorder Mechanism Inheritance Key Features Diagnostic Findings Management
Hereditary Spherocytosis Cytoskeletal defect (spectrin/ankyrin) Autosomal dominant Splenomegaly, gallstones, aplastic crises Spherocytes, increased MCHC, osmotic fragility Folate, splenectomy for severe cases
G6PD Deficiency Oxidative stress vulnerability X-linked recessive Drug/illness triggered, favism, self-limited Heinz bodies, bite cells, low G6PD activity Avoid triggers, supportive care during crises
Sickle Cell Disease HbS polymerization Autosomal recessive Vaso-occlusive crises, infections, organ damage Sickled cells, target cells, Hb electrophoresis Hydroxyurea, transfusions, pain management
Autoimmune Hemolytic Autoantibody-mediated destruction Acquired Warm/cold types, underlying autoimmune disease Spherocytes, +Direct Coombs, reticulocytosis Corticosteroids, immunosuppressants, rituximab
🔬 Laboratory Hallmarks of Hemolysis: Elevated LDH, indirect bilirubin, and reticulocyte count with decreased haptoglobin. The pattern of these markers helps confirm hemolysis and may provide clues to the underlying mechanism.

🩺 Systematic Diagnostic Approach

A methodical approach to anemia evaluation ensures comprehensive assessment while efficiently directing resources toward the most likely diagnoses:

Initial Assessment

  • Confirm Anemia: Repeat CBC if questionable
  • Assess Severity: Hemoglobin level, symptoms
  • Check Reticulocytes: Production vs. destruction
  • Determine MCV: Morphological classification
  • Review Peripheral Smear: Cellular morphology
  • Clinical Context: Symptoms, signs, comorbidities

Directed Evaluation

  • Microcytic: Iron studies, hemoglobin electrophoresis
  • Normocytic: Reticulocyte count, Coombs test, renal function
  • Macrocytic: B12, folate, thyroid function, LFTs
  • Hemolytic Pattern: LDH, bilirubin, haptoglobin, Coombs
  • Bone Marrow Failure: Pancytopenia evaluation
  • Specialized Testing: Based on initial findings

Clinical Correlation

  • History: Bleeding, diet, family history, medications
  • Physical Exam: Pallor, jaundice, splenomegaly, specific signs
  • Comorbidities: Renal, hepatic, inflammatory diseases
  • Medication Review: Drug-induced causes
  • Social History: Alcohol, occupation, travel
  • Family History: Inherited disorders

🎯 Clinical Pearls & Therapeutic Principles

Effective anemia management requires understanding both the hematological abnormalities and their underlying causes, with treatment strategies tailored to specific etiologies:

  • Transfusion decisions should consider symptoms, hemodynamic status, and chronicity rather than hemoglobin levels alone
  • Iron studies can be misleading in inflammatory states; ferritin is an acute phase reactant
  • Response to iron therapy typically shows reticulocyte peak at 7-10 days and hemoglobin normalization in 6-8 weeks
  • Pernicious anemia requires lifelong B12 monitoring and typically parenteral administration
  • Hemolytic anemias may require folate supplementation due to increased RBC turnover
  • Always investigate the cause of anemia rather than simply treating the laboratory abnormality
🔬 Pathology Study Tips:
  • Master the MCV approach: This is the single most useful classification system
  • Understand iron physiology: Know the progression from storage depletion to anemia
  • Differentiate B12/folate: Neurological symptoms are the key distinction
  • Recognize hemolytic patterns: Know the laboratory hallmarks of increased destruction
  • Connect morphology to mechanism: Relate RBC appearance to underlying pathophysiology
⚠️ Critical Concept: Anemia is a clinical sign, not a final diagnosis. The imperative is always to identify and address the underlying cause, whether it's occult malignancy, inherited disorder, nutritional deficiency, or systemic disease. Comprehensive evaluation prevents missed serious diagnoses and ensures appropriate management.

🌟 Comprehensive Anemia Management

The clinical approach to anemia represents a fundamental medical skill, integrating laboratory interpretation, pathophysiological understanding, and clinical reasoning. From the global health challenge of iron deficiency to the complex management of inherited hemolytic disorders, anemia encompasses a spectrum of conditions requiring tailored diagnostic and therapeutic strategies.

Mastering anemia evaluation not only addresses immediate hematological concerns but also serves as a window into broader patient health, revealing nutritional status, chronic diseases, inherited conditions, and occasionally life-threatening acute pathologies. The systematic approach outlined provides a framework for efficient, comprehensive patient care across diverse clinical settings.

The Hematological Compass: "Anemia serves as both a common clinical problem and a diagnostic compass—pointing toward underlying systemic disorders, nutritional status, genetic conditions, and sometimes emergent pathologies. A meticulous approach to its evaluation often reveals critical insights extending far beyond the hematological system alone."

← Previous Topic: Adrenal Disorders Next Topic: Leukemias and Lymphomas →